160 filings
8-K
ONYX Pharmaceuticals Inc
1 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
ONYX Pharmaceuticals Inc
24 Sep 13
Other Events
12:00am
8-K
ONYX Pharmaceuticals Inc
26 Aug 13
Amgen to Acquire Onyx Pharmaceuticals
12:00am
8-K
ONYX Pharmaceuticals Inc
8 Aug 13
Onyx Pharmaceuticals Reports Second Quarter 2013 Financial Results
12:00am
8-K
ONYX Pharmaceuticals Inc
31 Jul 13
Results of Operations and Financial Condition
12:00am
8-K
ey1igpw2hs7xe
1 Jul 13
Onyx Pharmaceuticals Confirms Receipt of Unsolicited Acquisition Proposal from Amgen
12:00am
8-K
w18ywewu57e8f24w8
23 May 13
Departure of Directors or Certain Officers
12:00am
8-K
7luo5ve0pau04 3lc
7 May 13
Onyx Pharmaceuticals Reports First Quarter 2013 Financial Results
12:00am
8-K
fnzvpylh1j 2huqscnt
25 Apr 13
Results of Operations and Financial Condition
12:00am
8-K
ftxen
11 Mar 13
Regulation FD Disclosure
12:00am
8-K
6f4s 0o5bq
21 Feb 13
Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2012 Financial Results
12:00am
8-K
19ydvm7r0umsdz7f
11 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
tdavlebg6
17 Jan 13
Onyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12:00am
8-K
jrle37jef4o0a16
7 Jan 13
Onyx Pharmaceuticals Announces 2013 Updates and Reviews 2012 Achievements at J.P. Morgan Healthcare Conference
12:00am
8-K
02g yzztj
1 Nov 12
Onyx Pharmaceuticals Reports Third Quarter 2012 Financial Results
12:00am
8-K
io0wyaihuytzguriyui
27 Sep 12
Bayer’s Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
12:00am
8-K
l6lwn
1 Aug 12
Onyx Pharmaceuticals Reports Second Quarter 2012 Financial Results
12:00am
8-K
9ckaiz40
31 Jul 12
Results of Operations and Financial Condition
12:00am
8-K/A
h0y96nz6w93cbfmj
20 Jul 12
Other Events
12:00am
8-K
jay lsuv9gvseajttpf
20 Jul 12
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolis™ (carfilzomib) for Injection
12:00am